Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yellow fever protection 8 years after fractional-dose 17DD vaccination
RBR-7yrysy5Recruiting
- Sponsor
- Instituto René Rachou
- Start
- Sep 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of 17DD yellow fever vaccine in yellow fever (3 arms), sponsored by Instituto René Rachou. Primary endpoint: Neutralizing antibody quantification. Started Sep 2025; status: recruiting.
02
Drugs
17DD yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on RBR-7yrysy5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7yrysy5.